Atezolizumab plus bevacizumab

Open Access
Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO and KENTA MOTOMURA

In Vivo July 2024, 38 (4) 1854-1858; DOI: https://doi.org/10.21873/invivo.13639
Open Access
Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases
TOSHIHIKO MOTOHARA, KENSUKE YAMAMURA, HIDEAKI MIYAMOTO, SHIGENORI UENO, HIROSHI TAKENO, YASUNORI NAGAYAMA, ERI ODA, RYUICHI KARASHIMA, NOBUYUKI OZAKI, TATSUNORI MIYATA, KOSUKE MIMA, HIROHISA OKABE, TAKATOSHI ISIKO and TORU BEPPU

In Vivo September 2023, 37 (5) 2268-2275; DOI: https://doi.org/10.21873/invivo.13329

Main menu